跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,951 条关于
“Septerna Inc.”
全部
40,951
临床试验
11,232
药物
1,619
机构
6,169
资讯
21,931
去年
Septerna Halts Phase I Trial of Hypoparathyroidism Drug SEP-786 Due to Safety Concerns
去年
Septerna Halts Phase 1 Trial of SEP-786 for Hypoparathyroidism Due to Safety Concerns
7个月前
Septerna Advances MRGPRX2 Inhibitor SEP-631 to Clinical Testing for Chronic Urticaria and Mast Cell Disorders
25天前
Septerna Appoints Industry Veteran Rajiv Patni, M.D., as Chief Medical Officer
11个月前
Septerna Appoints Keith Gottesdiener as Board Director and R&D Committee Chair
去年
Septerna Initiates First-in-Human Trial of SEP-631 for Chronic Spontaneous Urticaria
11个月前
Monash University Establishes Boston Hub to Accelerate Global Drug Discovery Partnerships
去年
Septerna Raises $288M in Upsized IPO to Advance Novel GPCR-Targeting Drug Pipeline
去年
Novo Nordisk and Septerna Partner on $2.2 Billion Deal to Develop Oral Obesity Treatments
去年
Septerna Initiates Phase 1 Trial of Oral PTH1R Agonist SEP-786 for Hypoparathyroidism
第 1 页,共 2194 页
上一页
下一页